The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,258.00
Bid: 12,256.00
Ask: 12,258.00
Change: -146.00 (-1.18%)
Spread: 2.00 (0.016%)
Open: 12,334.00
High: 12,362.00
Low: 12,254.00
Prev. Close: 12,404.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 2-Tropical Malaysia works to boost cold-storage, get more COVID-19 shots

Wed, 23rd Dec 2020 07:47

* Delivery map for vaccines needing ultra-cold storage

* Final talks with Russian and Chinese vaccine makers

* Aims to double AstraZeneca vaccines, buy more from Pfizer

* In talks with Moderna Inc, Johnson & Johnson
(Recasts, adds details on vaccine logistics)

By Liz Lee

KUALA LUMPUR, Dec 23 (Reuters) - Malaysia said on Wednesday
it was talking with Pfizer and other companies to secure
more COVID-19 vaccine doses to cover 83% of its population, and
is drawing up plans to arrange ultra-cold storage in its
tropical heat.

The Southeast Asian nation says it has so far got enough
doses to inoculate 40% of its 32 million people, and has
promised to spend $500 million to buy enough vaccines.

The government, which has struck a deal to buy 12.8 million
doses of U.S. drugmaker Pfizer-BioNTech's shot, said it was in
talks for an option to buy more doses to cover another fifth of
the population.

It is also in final talks to secure a total of 23.9 million
doses from Chinese manufacturers Sinovac Biotech Ltd and
CanSino Biologics, and from Russia's Gamaleya Institute, the
maker of the Sputnik V vaccine, Science Minister Khairy
Jamaluddin said.

It will secure additional AstraZeneca vaccines under
the global COVAX facility, and has begun talks with Moderna
and Johnson & Johnson as a buffer, the minister
added.

Malaysia, where temperatures average 30 degrees Celsius
year-round, wants to ensure a distribution network that does not
need to store vaccines for long, Khairy said.

"Once the Pfizer vaccines come in, we are hoping that it
will be a just-in-time roll out of vaccination," he said.

Pfizer's vaccines need to be stored and transported at minus
70 degrees Celsius (-94F), although they can be kept in a fridge
for up to five days, or up to 15 days in a thermal shipping box.

Some Asian countries have expressed reservations about the
Pfizer vaccine due to tropical heat, remote island communities
and a lack of ultra-cold freezers.

Malaysian's vaccine supply committee will identify
ultra-cold storage facilities and aims to stagger distribution
to ensure coverage in remote regions, ahead of the arrival of
Pfizer's first shipment in February, Khairy said.

Neighbouring Singapore was the first Asian nation to take
delivery of a batch of the Pfizer vaccine on Monday from
Belgium.

(Writing by Rozanna Latiff; Editing by Himani Sarkar, Michael
Perry abd Andrew Heavens)

More News
11 Apr 2024 17:07

Banks weigh down Europe's STOXX 600 after ECB signals rate cuts

Outlook hike sends Ambu shares up

*

Read more
11 Apr 2024 15:56

London close: Stocks finish lower as ECB stands pat

(Sharecast News) - London's stock markets finished in negative territory on Thursday, as investors reacted to the European Central Bank's latest policy announcement and a producer price index release in the United States.

Read more
11 Apr 2024 11:50

LONDON MARKET MIDDAY: Europe takes hit on nerves ahead of ECB decision

(Alliance News) - European equities sunk lower at midday on Thursday, with sentiment hurt by hotter-than-expected inflation from the US crushing hopes of interest rate cuts.

Read more
11 Apr 2024 08:56

TOP NEWS: Astra plans 7% dividend hike for 2024 after no rise in 2023

(Alliance News) - AstraZeneca PLC said it intends to raise its annualised dividend for 2024, citing confidence in its business performance and cash generation.

Read more
11 Apr 2024 08:54

LONDON MARKET OPEN: European markets mixed ahead of ECB decision

(Alliance News) - European equities lacked direction early Thursday morning, ahead of an interest rate decision from the European Central Bank this afternoon.

Read more
11 Apr 2024 07:49

LONDON BRIEFING: Astra promises dividend hike; Darktrace ups guidance

(Alliance News) - Stocks in London are called to open slightly higher on Thursday, as investors eye the latest interest rate decision from the European Central Bank, a day after a hotter-than-expected US inflation reading.

Read more
11 Apr 2024 07:20

AstraZeneca to hike 2024 dividend by 7%

(Sharecast News) - Biopharma giant AstraZeneca has announced that it will increase its annual dividend by 7%, which the board said demonstrates its confidence in the company's performance and cash generation.

Read more
8 Apr 2024 08:36

TOP NEWS: AstraZeneca hails neurological data for Ultomiris, Soliris

(Alliance News) - AstraZeneca PLC on Monday said long-term data in generalised myasthenia gravis will underscore the "vital role" of its Ultomiris and Soliris antibodies in the treatment landscape.

Read more
8 Apr 2024 07:43

LONDON BRIEFING: Astra hails neurology data; CVS flags cyberattack

(Alliance News) - London's FTSE 100 is called to open a touch higher on Monday, ahead of an interest rate decision in the eurozone and a US inflation reading later in the week.

Read more
8 Apr 2024 07:02

AstraZeneca's Enhurtu cancer gets US green light for adult patients

(Sharecast News) - AstraZeneca and Daiichi Sankyo's Enhertu cancer drug has been approved in the US for adult patients with unresectable or metastatic solid tumours who have received prior systemic treatment and have no satisfactory alternative options.

Read more
8 Apr 2024 06:53

TOP NEWS: AstraZeneca's, Daiichi's Enhertu receives US FDA approval

(Alliance News) - AstraZeneca PLC and Daiichi Sankyo Co Ltd on Saturday announced that the US Food & Drug Administration has approved their cancer drug conjugate for patients with metastatic HER2-positive solid tumours.

Read more
5 Apr 2024 09:42

AstraZeneca makes "breakthrough" in treating small cell lung cancer

(Alliance News) - AstraZeneca PLC on Friday reported positive results relating to its Imfinzi cancer treatment in phase III trials.

Read more
5 Apr 2024 07:50

LONDON BRIEFING: Shell to book USD600 million first-quarter write-off

(Alliance News) - London's FTSE 100 is called to open lower on Friday, with hawkish remarks from Federal Reserve policymakers and fears of ratcheting Middle East tensions giving investors little to cheer about ahead of the latest US jobs data.

Read more
5 Apr 2024 07:23

AstraZeneca announces positive lung cancer treatment trial results

(Sharecast News) - AstraZeneca announced positive high-level results from a phase three trial demonstrating significant advancements in the treatment of limited-stage small cell lung cancer (LS-SCLC) on Friday.

Read more
4 Apr 2024 13:09

UK shareholder meetings calendar - next 7 days

Friday 5 April 
Faron Pharmaceuticals LtdAGM
VPC Specialty Lending Investments PLCGM re capital return via B share scheme
Monday 8 April 
Premier African Minerals LtdAGM
Tuesday 9 April 
Ethernity Networks LtdEGM re board appointments and option grants
Wednesday 10 April 
Valereum PLCAGM
Wincanton PLCGM re takeover by GXO Logistics Inc
Thursday 11 April 
AstraZeneca PLCAGM
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.